Drug
CKD-828 clinical trials
Also written CKD-828.
- studies test it
- 11
- open now
- 0
- in phase 3
- 2
- first study started
- 2010
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
11 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Often tested with
Tested in the same studies.
CKD-348 (1) · Multimodality Therapy (1) · D326 (1) · D337 (1)
Studies
Open first, then newest update. How each study uses CKD-828 is read from its arms, and is right about nine times in ten.
Testing it · 11
- A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mgCompletedPhase 1Chong Kun Dang PharmaceuticalNCT05881707Written as CKD-828, D064, D702
- A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828CompletedPhase 1Chong Kun Dang PharmaceuticalNCT05834595Written as CKD-828, D064, D701
- Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy SubjectsCompletedPhase 1Chong Kun Dang PharmaceuticalNCT05540912Written as CKD-828 Formulation 1
- Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy VolunteersCompletedPhase 1Chong Kun Dang PharmaceuticalNCT04304547Written as CKD-828, D097, D337, CKD-348 T1, CKD-348 T2
- Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) TabletStatus unknownPhase 3Chong Kun Dang PharmaceuticalNCT04388215Written as CKD-828
- CKD-828 (80/5mg) Pharmacokinetic StudyCompletedPhase 1Chong Kun Dang PharmaceuticalNCT02358824Written as CKD-828
- CKD-828 (80/5mg) Pharmacokinetic StudyCompletedPhase 1Chong Kun Dang PharmaceuticalNCT02250833Written as CKD-828
- Efficacy and Safety of CKD-828 to Stage 2 HypertensionCompletedPhase 3Chong Kun Dang PharmaceuticalNCT01634295Written as CKD-828 2.5/40mg
- CKD-828(80/2.5mg) Pharmacokinetic Study_2ndCompletedPhase 1Chong Kun Dang PharmaceuticalNCT01352689Written as CKD-828(FDC)
- CKD-828 (40/5mg) Pharmacokinetic StudyCompletedPhase 1Chong Kun Dang PharmaceuticalNCT01340131Written as CKD-828
- CKD-828(80/2.5mg) Pharmacokinetic StudyCompletedPhase 1Chong Kun Dang PharmaceuticalNCT01246193Written as CKD-828(FDC)